The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The EVER Proteins as a Natural Barrier against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections
Abstract
SUMMARY: Infections by human papillomaviruses (HPVs) are the most frequently occurring sexually transmitted diseases. The crucial role of genital oncogenic HPV in cervical carcinoma development is now well established. In contrast, the role of cutaneous HPV in skin cancer development remains a matter of debate. Cutaneous beta-HPV strains show an amazing ubiquity. The fact that a few oncogenic genotypes cause cancers in patients suffering from epidermodysplasia verruciformis is in sharp contrast to the unapparent course of infection in the general population. Our recent investigations revealed that a natural barrier exists in humans, which protects them against infection with these papillomaviruses. A central role in the function of this HPV-specific barrier is played by a complex of the zinc-transporting proteins EVER1, EVER2, and ZnT-1, which maintain cellular zinc homeostasis. Apparently, the deregulation of the cellular zinc balance emerges as an important step in the life cycles not only of cutaneous but also of genital HPVs, although the latter viruses have developed a mechanism by which they can break the barrier and impose a zinc imbalance. Herein, we present a previously unpublished list of the cellular partners of EVER proteins, which points to future directions concerning investigations of the mechanisms of action of the EVER/ZnT-1 complex. We also present a general overview of the pathogenesis of HPV infections, taking into account the latest discoveries regarding the role of cellular zinc homeostasis in the HPV life cycle. We propose a potential model for the mechanism of function of the anti-HPV barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The EVER proteins may regulate zinc distribution in T cells, as suggested by Lazarczyk et al. (54).”
From Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections (2012) · cites this paper as [54]
In the citing paper
“In the literature, there are currently 2 hypotheses, not mutually exclusive, to explain the pathogenesis of EV in EVER deficiency: EVER deficiency alleviates the inhibition of the expression of the whole genome of EV-HPVs in keratinocytes, and EVER deficiency impairs T cell immunity against EV-HPVs (15,54).”
From Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections (2012) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Femtomolar Sensitivity of Metalloregulatory Proteins Controlling Zinc Homeostasis
Outten, C. E., & O'Halloran, A. T. V. (2001) · Science · doi:10.1126/science.1060331 · Cited by 1,489 · cited 1×
“It remains to be determined whether cellular factors indeed “deliver” this element to the viral proteins, serving as metallochaperones (48, 156), or, conversely, whether Zn(2) is acquired directly by HPV proteins from the pool of free ions.”
BackgroundChapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Molecular biology of human papillomavirus infection and cervical cancer
Doorbar, J. (2006) · Clinical Science · doi:10.1042/cs20050369 · Cited by 1,072
Hernandez, P. A., Gorlin, R. J., Lukens, J. N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M. E., & Diaz, G. A. (2003) · Nature Genetics · doi:10.1038/ng1149 · Cited by 722 · cited 1×
“tions in the CXCR4 chemokine receptor gene (82), leading to”
BackgroundNarisawa‐Saito, M., & Kiyono, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00546.x · Cited by 528
Research works printed but not linked: 232
- 10.1007/s00705-006-0806-z · DOI
- 10.1002/gene.20067 · DOI
- 10.1001/archderm.1985.01660070054014 · DOI
- 10.1128/JVI.74.24.11636-11641.2000 · DOI
- 10.1128/JCM.41.6.2509-2514.2003 · DOI
- 10.1111/j.1651-2227.1986.tb10328.x · DOI
- 10.1002/ijc.22089 · DOI · Paper page
- 10.1379/1466-1268(2000)005<0196:COTMGF>2.0.CO;2 · DOI
- Ault, K. A. 2006. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect. Dis. Obstet. Gynecol.2006(Suppl.):40470. · DOI
- 10.1001/archderm.141.10.1323 · DOI
- 10.1084/jem.189.10.1521 · DOI
- 10.1182/blood-2004-06-2289 · DOI
- Balabanian, K., A. Levoye, L. Klemm, B. Lagane, O. Hermine, J. Harriague, F. Baleux, F. Arenzana-Seisdedos, and F. Bachelerie. 2008. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J. Clin. Investig.118:1074-1084.
- 10.1128/jvi.63.3.1404-1407.1989 · DOI · Paper page
- 10.1016/j.abb.2007.04.015 · DOI
- 10.1111/1523-1747.ep12525278 · DOI
- 10.1083/jcb.61.1.45 · DOI
- Bernard, H. U. 2005. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J. Clin. Virol.32(Suppl. 1):S1-S6.
- 10.1001/archderm.1994.01690020076013 · DOI
- 10.1038/jid.2008.123 · DOI
- Braakhuis, B. J., P. J. Snijders, and C. R. Leemans. 2007. Human papillomavirus and oropharyngeal cancer. N. Engl. J. Med.357:1157; author reply 1157-1158.
- 10.1128/JVI.78.24.13613-13626.2004 · DOI · Paper page
- 10.1007/s11262-006-0017-4 · DOI
- Burk, R. D., M. Terai, P. E. Gravitt, L. A. Brinton, R. J. Kurman, W. A. Barnes, M. D. Greenberg, O. C. Hadjimichael, L. Fu, L. McGowan, R. Mortel, P. E. Schwartz, and A. Hildesheim. 2003. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res.63:7215-7220.
- 10.1128/JVI.77.3.2195-2206.2003 · DOI
- 10.1093/jnci/djj067 · DOI
- 10.1007/BF02256414 · DOI · Paper page
- 10.1101/gad.9.19.2335 · DOI
- 10.1099/0022-1317-71-2-449 · DOI
- 10.1128/jvi.65.11.5933-5943.1991 · DOI
- 10.1038/sj.bjc.6600688 · DOI
- 10.1128/jvi.67.10.6170-6178.1993 · DOI
- 10.1016/j.jcv.2006.04.003 · DOI
- 10.1073/pnas.82.20.7035 · DOI
- 10.1099/vir.0.82732-0 · DOI
- 10.1038/jid.2008.317 · DOI
- 10.1016/j.virol.2004.03.033 · DOI
- 10.1016/S0065-3527(06)66003-X · DOI
- 10.1016/j.jcv.2004.12.006 · DOI
- 10.1155/2007/613150 · DOI
- 10.1038/352824a0 · DOI
- Driessen, C., K. Hirv, L. Rink, and H. Kirchner. 1994. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphok. Cytok. Res.13:15-20.
- 10.1056/NEJMoa065497 · DOI
- 10.1073/pnas.170093297 · DOI · Paper page
- 10.1001/jama.297.8.813 · DOI
- 10.1159/000073085 · DOI
- 10.1016/j.bbamcr.2006.03.005 · DOI · Paper page
- 10.1016/j.canlet.2006.05.010 · DOI
- 10.1124/mol.59.5.981 · DOI
- 10.1128/jvi.21.3.1205-1209.1977 · DOI
- 10.1046/j.1523-1747.2000.00892.x · DOI
- 10.1046/j.1523-1747.1998.00164.x · DOI
- 10.1016/S0738-081X(97)00008-4 · DOI
- 10.1073/pnas.76.1.457 · DOI
- 10.1099/0022-1317-80-9-2437 · DOI
- 10.1086/521031 · DOI
- 10.1146/annurev.nutr.24.012003.132454 · DOI · Paper page
- 10.1073/pnas.91.26.12398 · DOI
- 10.1006/viro.1994.1596 · DOI
- Frisch, M. 2002. On the etiology of anal squamous carcinoma. Dan. Med. Bull.49:194-209.
- 10.1016/j.tim.2005.09.003 · DOI
- 10.1111/j.1365-2141.2004.05176.x · DOI
- 10.1097/QCO.0b013e3282f486c9 · DOI
- 10.1002/1096-9896(2000)9999:9999<::AID-PATH809>3.0.CO;2-C · DOI
- 10.1128/JVI.75.3.1565-1570.2001 · DOI
- Giuliano, A. R., B. Lu, C. M. Nielson, R. Flores, M. R. Papenfuss, J. H. Lee, M. Abrahamsen, and R. B. Harris. 2008. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J. Infect. Dis.198:827-835.
- 10.1159/000251060 · DOI
- 10.1159/000250262 · DOI
- 10.1128/JVI.02571-05 · DOI
- 10.1093/molbev/msm039 · DOI
- Grossman, S. R., and L. A. Laimins. 1989. E6 protein of human papillomavirus type 18 binds zinc. Oncogene4:1089-1093.
- Gulino, A. V., D. Moratto, S. Sozzani, P. Cavadini, K. Otero, L. Tassone, L. Imberti, S. Pirovano, L. D. Notarangelo, R. Soresina, E. Mazzolari, D. L. Nelson, L. D. Notarangelo, and R. Badolato. 2004. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood104:444-452.
- 10.1016/S0014-4827(03)00406-3 · DOI
- 10.1002/1096-9071(200007)61:3<289::AID-JMV2>3.0.CO;2-Z · DOI
- 10.1111/j.1365-2133.2004.05847.x · DOI
- 10.1016/j.virol.2007.03.004 · DOI
- Hebert, A. A., and M. D. Lopez. 1997. Oral lesions in pediatric patients. Adv. Dermatol.12:169-193; discussion 194.
- 10.1002/rmv.488 · DOI
- 10.1073/pnas.89.10.4442 · DOI
- 10.1007/s10522-006-9056-4 · DOI
- 10.1242/jcs.01589 · DOI
- 10.1002/j.1460-2075.1994.tb06581.x · DOI
- 10.1054/bjoc.2001.1779 · DOI
- 10.1006/viro.1993.1524 · DOI
- 10.1128/JVI.00881-07 · DOI · Paper page
- 10.1074/jbc.273.30.18729 · DOI
- Iversen, T., and S. Tretli. 1998. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet. Gynecol.91:969-972.
- Jablonska, S., J. Dabrowski, and K. Jakubowicz. 1972. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res.32:583-589.
- 10.1038/sj.bjc.6600431 · DOI
- 10.1101/gad.182100 · DOI
- 10.1097/01.AOG.0000210237.80211.ff · DOI
- 10.1074/jbc.274.9.5810 · DOI
- 10.1128/JVI.76.23.12162-12172.2002 · DOI
- 10.1002/ijc.23707 · DOI
- 10.1016/0042-6822(91)90523-E · DOI
- 10.1016/S0168-1702(97)01464-0 · DOI
- 10.1016/j.immuni.2007.11.002 · DOI
- 10.1016/j.exphem.2005.01.001 · DOI
- 10.1186/1471-2164-4-24 · DOI
- 10.1126/science.1085643 · DOI
- 10.1152/ajplung.00479.2005 · DOI
- 10.1093/jn/132.5.974 · DOI
- 10.1016/0014-4827(70)90284-3 · DOI
- 10.1038/ni1373 · DOI
- 10.1093/aje/kwn036 · DOI
- 10.1016/j.bbrc.2008.04.122 · DOI
- 10.1016/S0888-7543(03)00154-X · DOI
- 10.1093/jnci/djg091 · DOI
- 10.1099/0022-1317-78-2-401 · DOI
- 10.1016/S0140-6736(04)16457-X · DOI · Paper page
- 10.1016/S0959-440X(00)00167-6 · DOI
- 10.1074/jbc.M007339200 · DOI
- 10.1128/JVI.01314-08 · DOI
- 10.1084/jem.20071311 · DOI · Paper page
- 10.1051/medsci/2005212125 · DOI
- 10.1007/s10495-006-0004-1 · DOI
- 10.1038/sj.onc.1201798 · DOI
- 10.1074/jbc.273.49.32878 · DOI
- 10.1021/bi001837 · DOI
- 10.1073/pnas.0406216101 · DOI
- 10.1146/annurev.nutr.24.012003.132402 · DOI
- 10.1128/JVI.78.7.3533-3541.2004 · DOI
- 10.1128/MMBR.68.2.362-372.2004 · DOI
- 10.1016/j.ejso.2007.11.007 · DOI
- 10.1111/1523-1747.ep12531131 · DOI
- Lutzner, M. A. 1978. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull. Cancer65:169-182.
- 10.1073/pnas.88.20.9102 · DOI
- 10.1046/j.1523-1747.1998.00310.x · DOI
- 10.1111/1523-1747.ep12491539 · DOI
- 10.1016/S0190-9622(97)80315-5 · DOI
- 10.1007/s10495-005-0811-9 · DOI
- 10.1128/jvi.68.6.3612-3619.1994 · DOI
- 10.1128/jvi.67.6.3142-3150.1993 · DOI · Paper page
- 10.1002/(SICI)1098-2744(199707)19:2<83::AID-MC3>3.0.CO;2-M · DOI
- 10.1128/JVI.02576-05 · DOI
- 10.1159/000051786 · DOI
- 10.1126/science.2176744 · DOI
- 10.1093/aje/kwg171 · DOI
- 10.1016/S0168-1702(02)00190-9 · DOI
- 10.1056/NEJMoa021641 · DOI · Paper page
- 10.1016/j.jaci.2004.06.044 · DOI
- 10.1111/1523-1747.ep12460892 · DOI
- 10.1128/jvi.64.10.4792-4798.1990 · DOI
- 10.1074/jbc.M309229200 · DOI
- 10.1038/sj.onc.1209584 · DOI
- 10.1128/JVI.78.19.10738-10746.2004 · DOI
- Orth, G. 1987. Epidermodysplasia verruciformis, p. 199-243. In N. P. Salzman and P. M. Howley (ed.), the papovaviridae: the papillomaviruses. Plenum Press, New York, NY.
- 10.1016/j.smim.2006.07.008 · DOI · Paper page
- Orth, G. 2005. Human papillomaviruses associated with epidermodysplasia verruciformis in non-melanoma skin cancers: guilty or innocent? J. Investig. Dermatol.125:xii-xiii.
- Orth, G. 1999. Papillomaviruses—human (papovaviridae): general features, p. 1105-1114. In A. Granoff and R. G. Webster (ed.), Encyclopedia of Virology, 2nd ed. Academic Press, London, United Kingdom.
- Orth, G., M. Favre, F. Breitburd, O. Croissant, S. Jablonska, and S. Obalek. 1980. Epidermodysplasia verruciformis: a model for the role of papillomaviruses in human cancer. Cold Spring Harb. Conf. Cell Prolif.7:259-282.
- 10.1155/2007/159137 · DOI
- 10.1002/j.1460-2075.1995.tb07042.x · DOI
- 10.1002/ijc.23377 · DOI
- Patrick, J., J. Michael, M. N. Golden, B. E. Golden, and P. J. Hilton. 1978. Effect of zinc on leucocyte sodium transport in vitro. Clin. Sci. Mol. Med.54:585-587.
- 10.1128/JCM.40.3.886-891.2002 · DOI
- 10.1099/0022-1317-76-8-1945 · DOI
- 10.1002/path.2192 · DOI
- 10.1038/jid.2008.73 · DOI
- 10.1007/s00403-003-0435-2 · DOI
- 10.1016/S0738-081X(96)00157-5 · DOI
- 10.1023/A:1006868305749 · DOI
- 10.1001/archderm.1977.01640040103018 · DOI
- Premoli-De-Percoco, G., J. P. Cisternas, J. L. Ramirez, and I. Galindo. 1993. Focal epithelial hyperplasia: human-papillomavirus-induced disease with a genetic predisposition in a Venezuelan family. Hum. Genet.91:386-388.
- 10.1002/ijc.20668 · DOI
- 10.1111/j.0022-202X.2005.23635.x · DOI
- 10.1111/j.1365-2133.1980.tb08136.x · DOI
- 10.1002/j.1460-2075.1993.tb05780.x · DOI
- 10.1001/archderm.1972.01620040045008 · DOI
- 10.1046/j.1523-1747.1999.00536.x · DOI
- 10.1038/ng1044 · DOI
- 10.1046/j.1523-1747.2000.00996.x · DOI · Paper page
- 10.1001/archotol.129.9.976 · DOI
- 10.1128/JVI.01240-08 · DOI
- 10.1099/0022-1317-71-10-2457 · DOI
- 10.1023/A:1012986225203 · DOI
- 10.1006/jmbi.2000.4330 · DOI
- 10.1006/viro.1994.1408 · DOI
- 10.1038/sj.onc.1203718 · DOI
- 10.1016/S0021-9258(18)42015-7 · DOI
- Ruhl, H., and H. Kirchner. 1978. Monocyte-dependent stimulation of human T cells by zinc. Clin. Exp. Immunol.32:484-488.
- 10.1099/0022-1317-81-8-1983 · DOI
- 10.1158/0008-5472.CAN-04-3263 · DOI
- 10.1016/S0140-6736(07)61416-0 · DOI
- 10.1016/j.virol.2005.04.002 · DOI · Paper page
- 10.1128/jvi.61.10.3295-3298.1987 · DOI
- 10.2119/2007-00037.Sekler · DOI
- 10.1046/j.1471-4159.2001.00438.x · DOI
- 10.1101/gr.1239303 · DOI · Paper page
- 10.1074/jbc.275.13.9377 · DOI
- 10.1002/ijc.22527 · DOI
- 10.1002/(SICI)1097-0215(20000615)86:6<811::AID-IJC9>3.0.CO;2-J · DOI
- 10.1097/01.pas.0000213291.96401.48 · DOI
- 10.1006/viro.1996.0475 · DOI · Paper page
- 10.1128/jvi.69.5.3185-3192.1995 · DOI
- 10.1128/jvi.67.8.4521-4532.1993 · DOI · Paper page
- 10.1046/j.1523-1747.2003.12632.x · DOI
- 10.1128/JVI.73.3.1918-1930.1999 · DOI
- 10.1038/modpathol.3801010 · DOI
- 10.1016/0192-0561(89)90153-7 · DOI
200 of 232 shown
Cited by
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections
Crequer, A., Troeger, A., Patin, E., Ma, C. S., Picard, C., Pedergnana, V., Fieschi, C., Lim, A., Abhyankar, A., Gineau, L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62949 · Cited by 159
Metadata
- Authors
- Lazarczyk, M., Cassonnet, P., Pons, C., Jacob, Y., & Favre, M.
- Affiliations
- Institut Pasteur, Unité de Génétique, Papillomavirus et Cancer Humain, F-75015 Paris, France
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2009-06
- Volume
- 73
- Issue
- 2
- Pages
- 348-370
- ISSN
- 1092-2172
- 1098-5557
- Cited by
- 131
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review